Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...

Using our standard regimen (non-myeloablative total body irradiation, thymic irradiation, anti-thymocyte globulin, donor bone marrow infusion and a 1-month course of cyclosporine), we found no ...

In 2019, a meta-analysis suggested that the risk of coronary morbidity was 30% higher among Sjögren's patients than it was ...

Researchers at University Medical Center Maastricht and international partners report that a single shot of the drug zalunfiban given at first medical contact for suspected ST-elevation myocardial ...

Blood clots can form in both arteries and veins. Artery clots usually happen when plaque breaks off inside a blood vessel, ...

D printed blood vessels on glass that mimic blood vessel anatomy and the fluid dynamics of blood flow could be an invaluable tool in studying the causes of stroke, new research from a University of ...

Xeltis’ vascular access graft, aXess, recently demonstrated strong efficacy in an EU pivotal trial in patients with end-stage ...

Venous thrombosis, with blood clots formed in veins, may cause significant health risks like disability and cardiovascular death. Venous thrombosis normally occurs in the legs, but is infrequently ...

People with type 1 diabetes face two times increased risk of stent post-surgery complications than type 2 diabetic patients.

In Japan, health and longevity are thought to be supported by a number of simple daily rituals. We all know the basic ...

Diagnostic Challenges in Low-Resource Settings —A Six-Case Series. Neuroscience and Medicine, 16, 221-233. doi: ...

Topline data show the Factor XIa inhibitor asundexian lowers recurrent stroke risk vs placebo with no increase in major bleeding events.